ProPhase Labs, Inc. (PRPH) income statement
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 16.8%
- Operating margin
- -404.5%
- Net margin
- -583.9%
- Return on equity, FY2025
- -271.5%
Financial strength
- Current ratio
- 0.05
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.0%
Valuation
- P/E ratio
- –
- Price to sales
- 0.03
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?